Steven T. Rosen, MD, Provost and Chief Scientific Officer for City of Hope, has received a Lifetime Achievement Award from the Israel Cancer Research Fund (ICRF). The award recognizes Dr. Rosen’s longstanding commitment to advancing science and medicine and providing extraordinary patient care.
Dr. Rosen sets the scientific direction of City of Hope, shaping the research and educational vision for the independent biomedical research institution and cancer treatment center. Working closely and collaboratively with City of Hope’s scientists, clinicians, and administrative leaders, he develops strategies that help the organization quickly turn breakthrough discoveries into practical benefit for cancer patients around the world.
“This Lifetime Achievement Award is a remarkable honor, especially coming from the ICRF, an organization that advances scientific understanding of cancer and supports innovations that are transforming lives,” said Dr. Rosen, who serves as Director of City of Hope’s Comprehensive Cancer Center, Beckman Research Institute, and Irell & Manella Graduate School of Biological Sciences. He also holds the Irell & Manella Cancer Center Director’s Distinguished Chair. “I am extremely proud and humbled to be the recipient of such an honor.”
Earlier Career
Prior to joining City of Hope in 2014 as its first Provost and Chief Scientific Officer, Dr. Rosen served for 24 years as Director of Northwestern University’s Robert H. Lurie Comprehensive Cancer Center. He was also Northwestern’s Genevieve Teuton Professor of Medicine at the Feinberg School of Medicine, providing care for hundreds of patients with blood cancers and overseeing a basic science laboratory and clinical research team.
The National Cancer Institute (NCI), American Cancer Society, Leukemia & Lymphoma Society of America, and Multiple Myeloma Research Foundation have funded Dr. Rosen’s research. He’s also served as an adviser for several of these organizations and on the external advisory boards of more than a dozen NCI-designated comprehensive cancer centers.
The ICRF, the largest organization in North America devoted solely to supporting cancer research in Israel, has funded cancer research breakthroughs in gene therapy, bone marrow transplant techniques, molecular process, and drug therapies. ■
